ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Powers, NCI Still Disagree On Organ Systems Provisions

April 22, 1983

Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles

January 29, 1993

ACOS Survey To Assess Tumor Boards’ Impact On Patient Care

January 24, 1986

In Brief: Gori to Return As Head Of Smoking Program; Wisconsin, AACI To Honor Harold Rusch

May 18, 1979

University Of Illinois Cancer Center Director Kruh Dies

January 7, 2011

ACCC Presses Drive for “DG 471” But Former President Says it’s Counterproductive

March 30, 1984